Envoy Medical entered into a Dismissal Agreement to resolve litigation in the Delaware Court of Chancery brought by Atlas Merchant Capital SPAC Fund I LP. The dispute centered on Atlas's allegation that it was improperly denied redemption rights for its Class A Common Stock shares during the company's September 2023 business combination transaction. Under the agreement, all claims are dismissed with prejudice and no further proceedings will occur. Crucially, neither Envoy Medical nor any other defendant is required to make a payment to Atlas. The company operates in the medical device industry, specializing in minimally invasive surgical instruments.
